Navigation Links
New Report - Prospering in a Down Market: Strategies for Life Science Suppliers
Date:3/10/2009

ARLINGTON, Va., March 10 /PRNewswire/ -- BioInformatics, LLC announces availability of its newest report, Prospering in a Down Market: Strategies for Life Science Suppliers. In this report, BioInformatics, LLC (www.gene2drug.com), the premier research and advisory firm serving the life science market, provides hard data and analysis that supports fast -- and strategic -- decision-making for life science suppliers. BioInformatics, LLC fielded a detailed 45-question survey to more than 500 senior scientists and lab managers working in universities, pharmaceutical and biotechnology companies.

The report is available at pre-release pricing for the remainder of this week, until March 15, 2009. This special pricing is at a significant reduction off the regular pricing which will take effect next Monday, March 16, 2009.

Providing a roadmap for the life science supplier, this study compares and contrasts FY2008 (actual) and FY2009 (projected) lab budgets, revealing anticipated trends and changes. 14 product categories are examined using multiple variables, including current suppliers and projected expenditures through FY2010. The following companies were chosen most frequently as the primary supplier in at least one of the product categories:

    Affymetrix (Nasdaq:  AFFX)
    BD BioSciences (NYSE:  BDX)
    Bio-Rad Laboratories (NYSE:  BIO)
    Dell Computer Corp (Nasdaq:  DELL)
    Carl Zeiss
    Life Technologies (Nasdaq:  LIFE)
    PerkinElmer (NYSE:  PKI)
    Qiagen (Nasdaq:  QGEN)
    Thermo Fisher Scientific (NYSE:  TMO)

Life science suppliers plan to use this study to forecast economic trends to Boards of Directors, analysts and investors, and pinpoint areas of growth, stability and decline by market segment, region and product category. Scientists surveyed expressed their opinions as to how vendors can tailor marketing programs to enhance customer loyalty, and at what percentage price decrease they'd be willing to switch to lower cost suppliers. Ultimately, Prospering in a Down Market: Strategies for Life Science Suppliers will inform strategies in R&D, Product Development and Marketing/Sales.

"Nearly half of respondents surveyed said they are VERY worried that a recession will make it difficult for them to conduct their research and close to two-thirds indicated that their research has already been affected by the current economic recession," notes Tamara Zemlo, Ph.D., Vice President of Advisory Services. According to Zemlo, life sciences will likely fare better than other sectors of the economy, but she points out that scientists are employing a variety of ways to stretch their budgets. "Understanding how and where scientists intend to cut back will be essential for suppliers developing effective marketing and sales strategies."

To learn more about this report, a complimentary Executive Summary is available at http://www.gene2drug.com/reports/200/.

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 42,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

    For more information contact:

    Mary Follin
    Manager, Marketing/Sales
    BioInformatics, LLC
    2111 Wilson Blvd., Suite 250
    Arlington, VA  22201
    703.778.3080 x13 (phone)
    m.follin@gene2drug.com
   http://www.gene2drug.com/


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):